Sign In
Buy GERN
$1.16
-0.0100 (-0.85%)
At Close: Jun 03, 2026
AbbVie : Reports First-Quarter 2020 Financial Results | MarketScreener
11:44am, Friday, 01'st May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs May 1.)
Arcturus Therapeutics Ltd (...
Earnings Preview: Geron (GERN) Q1 Earnings Expected to Decline
12:00am, Thursday, 30'th Apr 2020
Apr 28, 2020 (The Expresswire) --
“Inflammatory Bowel Disease (IBD) Treatment Market” report 2020 delivers future development strategies, key companies,...
Bank of New York Mellon Corp Grows Position in Geron Co. (NASDAQ:GERN)
08:20am, Saturday, 25'th Apr 2020
Bank of New York Mellon Corp raised its holdings in shares of Geron Co. (NASDAQ:GERN) by 4.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities &
Geron Co. (NASDAQ:GERN) Receives Average Rating of "Buy" from Analysts
09:10am, Monday, 20'th Apr 2020
Geron Co. (NASDAQ:GERN) has received a consensus recommendation of “Buy” from the eight brokerages that are presently covering the company, Marketbeat.com reports. One analyst has rated the stock
Geron (NASDAQ:GERN) Is In A Good Position To Deliver On Growth Plans
02:06pm, Sunday, 12'th Apr 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
Clinical trials in the age of COVID: Shelter-in-place, hospital restrictions cause drug study delays
10:08pm, Thursday, 09'th Apr 2020
Sean McCarthy, president and CEO of CytomX Therapeutics Inc.
7 Penny Stocks To Buy with Massive Upside Potential
04:49pm, Wednesday, 08'th Apr 2020
There could be a reason these penny stocks trade for under $5, but returns could be monstrous with even minor share price appreciation.
Geron (NASDAQ:GERN) Trading Down 6.3%
10:04am, Wednesday, 08'th Apr 2020
Shares of Geron Co. (NASDAQ:GERN) fell 6.3% on Tuesday . The stock traded as low as $1.04 and last traded at $1.05, 1,111,553 shares were traded during trading. A decline of 26% from the average sessi
Geron Expects 2020 Spending To Be Lower Than The $70M-$75M Guidance Range
12:00am, Thursday, 02'nd Apr 2020Better Buy: Geron vs. Acceleron
12:49pm, Friday, 27'th Mar 2020
In this David versus Goliath battle, which biotech offers investors a greater return?
Top Stock Reports for Visa, Bank of America & Citigroup
04:14pm, Tuesday, 24'th Mar 2020
Top Stock Reports for Visa, Bank of America & Citigroup
Wall Street Analysts Are Bullish on Top Healthcare Picks
11:15am, Tuesday, 24'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Geron (GERN), Electrocore (ECOR) and CytomX Therapeutics
